Answer
Mifamurtide is indicated for high-grade resectable non-metastatic osteosarcoma in children, adolescents and young adults after macroscopically complete surgical resection, combined with post-operative multi-agent chemotherapy; safety and efficacy were assessed in patients aged 2–30 years at initial diagnosis.
Sources for this answer
- Mifamurtide 4 mg powder for concentrate for dispersion for infusionEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked